Oramed Debt To Assets from 2010 to 2024

ORMP Stock  USD 2.37  0.02  0.85%   
Oramed Pharmaceuticals Debt To Assets yearly trend continues to be relatively stable with very little volatility. Debt To Assets are likely to grow to 0.24 this year. During the period from 2010 to 2024, Oramed Pharmaceuticals Debt To Assets destribution of quarterly values had range of 0.4049 from its regression line and mean deviation of  0.07. View All Fundamentals
 
Debt To Assets  
First Reported
2010-12-31
Previous Quarter
0.23129798
Current Value
0.24
Quarterly Volatility
0.11297699
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oramed Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oramed Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 8.8 M, Other Operating Expenses of 10.7 M or Research Development of 7.6 M, as well as many indicators such as Price To Sales Ratio of 74.82, Dividend Yield of 0.0 or PTB Ratio of 0.6. Oramed financial statements analysis is a perfect complement when working with Oramed Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Oramed Pharmaceuticals Correlation against competitors.
To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.

Latest Oramed Pharmaceuticals' Debt To Assets Growth Pattern

Below is the plot of the Debt To Assets of Oramed Pharmaceuticals over the last few years. It is Oramed Pharmaceuticals' Debt To Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oramed Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Debt To Assets10 Years Trend
Pretty Stable
   Debt To Assets   
       Timeline  

Oramed Debt To Assets Regression Statistics

Arithmetic Mean0.02
Geometric Mean0.01
Coefficient Of Variation555.63
Mean Deviation0.07
Median0.0005
Standard Deviation0.11
Sample Variance0.01
Range0.4049
R-Value0.28
Mean Square Error0.01
R-Squared0.08
Significance0.31
Slope0.01
Total Sum of Squares0.18

Oramed Debt To Assets History

2024 0.24
2023 0.23
2021 0.005531
2020 0.004164
2019 0.00168
2017 -0.16
2016 4.65E-4

About Oramed Pharmaceuticals Financial Statements

Oramed Pharmaceuticals shareholders use historical fundamental indicators, such as Debt To Assets, to determine how well the company is positioned to perform in the future. Although Oramed Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Oramed Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Oramed Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Debt To Assets 0.23  0.24 

Pair Trading with Oramed Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oramed Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Oramed Stock

  0.61HLN Haleon plcPairCorr
  0.62PFE Pfizer Inc Aggressive PushPairCorr

Moving against Oramed Stock

  0.58FNMFO Federal National MortgagePairCorr
  0.47CIB Bancolombia SA ADRPairCorr
  0.44AVAL Grupo AvalPairCorr
  0.43TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.38AXP American Express Fiscal Year End 24th of January 2025 PairCorr
The ability to find closely correlated positions to Oramed Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oramed Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oramed Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oramed Pharmaceuticals to buy it.
The correlation of Oramed Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oramed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oramed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oramed Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Oramed Stock Analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.